Search details
1.
Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Arterioscler Thromb Vasc Biol
; 36(6): 1152-63, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27079878
2.
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
J Lipid Res
; 52(6): 1200-1210, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21444758
3.
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.
J Lipid Res
; 52(2): 361-73, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21068008
4.
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.
J Biol Chem
; 284(27): 18292-301, 2009 Jul 03.
Article
in English
| MEDLINE | ID: mdl-19433579
5.
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Mol Genet Metab
; 101(1): 66-75, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20619710
6.
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.
Nephrol Dial Transplant
; 25(11): 3525-34, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20488818
7.
The effect of HDL mimetic peptide 4F on PON1.
Adv Exp Med Biol
; 660: 167-72, 2010.
Article
in English
| MEDLINE | ID: mdl-20221879
8.
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
J Lipid Res
; 50(8): 1538-47, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19225094
9.
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
Clin Immunol
; 127(2): 234-44, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18337176
10.
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
Arterioscler Thromb Vasc Biol
; 27(6): 1368-74, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17446441
11.
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
Circ Res
; 97(8): 763-71, 2005 Oct 14.
Article
in English
| MEDLINE | ID: mdl-16151025
12.
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Circ Res
; 97(6): 524-32, 2005 Sep 16.
Article
in English
| MEDLINE | ID: mdl-16100046
13.
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.
Prostaglandins Other Lipid Mediat
; 84(1-2): 24-33, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17643885
14.
Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors.
J Appl Physiol (1985)
; 101(6): 1727-32, 2006 Dec.
Article
in English
| MEDLINE | ID: mdl-16902063
15.
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
Arterioscler Thromb Vasc Biol
; 25(7): 1426-32, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15845909
16.
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Arterioscler Thromb Vasc Biol
; 25(9): 1932-7, 2005 Sep.
Article
in English
| MEDLINE | ID: mdl-15961700
17.
Apolipoprotein A-I mimetic peptides.
Arterioscler Thromb Vasc Biol
; 25(7): 1325-31, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15831812
18.
Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
Circulation
; 108(14): 1735-9, 2003 Oct 07.
Article
in English
| MEDLINE | ID: mdl-14504179
19.
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation
; 105(3): 290-2, 2002 Jan 22.
Article
in English
| MEDLINE | ID: mdl-11804981
20.
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Circulation
; 108(22): 2751-6, 2003 Dec 02.
Article
in English
| MEDLINE | ID: mdl-14638544